Science
Mechanism of Action
Tetrapeptide-30 operates through a multifaceted approach to improve skin clarity and health. It primarily acts by reducing the activity of tyrosinase, an enzyme crucial for melanin production, and by inhibiting the activation of melanocytes, the cells responsible for pigment synthesis. This dual action significantly curtails the production and transfer of melanin to keratinocytes. Furthermore, it downregulates inflammatory cytokines such as IL-6, IL-8, and TNF-α, thereby suppressing inflammation-induced melanogenesis. The peptide also interferes with UV-induced signaling pathways (p53–POMC–α-MSH–MC1R cascade), which reduces cAMP and subsequently inhibits the PKA–CREB/MITF pathway, further dampening melanin production. Beyond pigmentation control, Tetrapeptide-30 exhibits anti-inflammatory properties, stimulates collagen synthesis, accelerates cellular turnover, improves skin elasticity, and provides antioxidant protection, contributing to a plumped, smoother complexion.
Research
Clinical Evidence
High confidence5%
Key findings
- 01 In-vivo studies demonstrated a noticeable reduction in yellow skin tone starting at 4 weeks, with age spots fading after 8 weeks. Significant improvements in overall skin appearance were observed as early as 2 weeks, alongside enhanced evenness of skin tone and a significant reduction in skin lesions within 4 weeks. Its efficacy is further amplified when co-formulated with Sodium Ascorbyl Phosphate.
Transparency
Dusting Analysis
There is no data to suggest that Tetrapeptide-30 is commonly 'dusted' in formulations, indicating that effective concentrations are typically employed.
The Formula
Formulation
Stability
To maintain optimal stability, Tetrapeptide-30 should not be exposed to temperatures exceeding 40°C (104°F). In O/W emulsions, it is best incorporated during the cooling phase below 40°C or directly into the water phase for cold-process formulations. For W/O emulsions, addition prior to homogenization below 30°C (86°F) or into the water phase of cold-process systems is recommended.
Synergies
- Sodium Ascorbyl Phosphate
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has not conducted a specific safety assessment for Tetrapeptide-30. While general peptide safety evaluations exist, they do not specifically address this ingredient. As is standard for cosmetic ingredients, products containing Tetrapeptide-30 are typically not evaluated by the FDA and are not intended to treat or prevent diseases.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Tetrapeptide-30 is a valuable, multifaceted peptide for addressing hyperpigmentation, uneven skin tone, and signs of aging with demonstrable clinical efficacy and broad skin compatibility.
Related
Similar Ingredients
Finding similar ingredients…